China Health Revenue Q/Q
What is the Revenue Q/Q of China Health?
The Revenue Q/Q of China Health Group Inc. is -16.97%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on HKSE compared to China Health
What does China Health do?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Companies with revenue q/q similar to China Health
- Johnson Matthey Plc has Revenue Q/Q of -17.00%
- ITE () has Revenue Q/Q of -17.00%
- Beijing PIESAT Information Technology Co has Revenue Q/Q of -16.99%
- Sandstorm Gold has Revenue Q/Q of -16.99%
- Datronix has Revenue Q/Q of -16.99%
- Sandstorm Gold has Revenue Q/Q of -16.98%
- China Health has Revenue Q/Q of -16.97%
- Atara Biotherapeutics has Revenue Q/Q of -16.96%
- Scorpio Bulkers has Revenue Q/Q of -16.95%
- Scorpio Bulkers Inc has Revenue Q/Q of -16.95%
- Iep Invest, NV has Revenue Q/Q of -16.93%
- Vishay Intertechnology has Revenue Q/Q of -16.91%
- The Tata Power has Revenue Q/Q of -16.91%